期刊文献+

生理盐水试验确诊原发性醛固酮增多症临床价值再评价 被引量:6

Revaluation of the clinical value of saline infusion test in diagnosis of primary aldosteronism
原文传递
导出
摘要 目的评价生理盐水试验确诊原发性醛固酮增多症的诊断价值。方法收集上海交通大学医学院附属瑞金医院内分泌科2006—2010年590例怀疑原发性醛固酮增多症患者的病例,其中有357例确诊为原发性醛固酮增多症,233例确诊为原发性高血压。回顾分析这些患者输注生理盐水后血醛固酮变化,绘制ROC曲线以找到合适的切点用来诊断原发性醛固酮增多症。结果输注生理盐水后血醛固酮ROC曲线下面积为0.975(0.959~0.986),曲线与参照曲线下面积0.5比较,差异有统计学意义(P<0.01)。生理盐水试验后血醛固酮大于277 pmol/L(100ng/L)时,诊断原醛症的敏感度及特异度分别为93%及97.8%。结论生理盐水抑制试验可作为原发性醛固酮增多症的确诊试验。 Objective To evaluate the diagnostic value of saline infusion test in diagnosis of primary aldosteronism (PA). Methods Between 2006 and 2010,590 cases with suspected PA registered in Department of Secretion, Ruijin Hospital were collected. Notably,357 cases were confirmed with PA and 233 cases with primary hypertension. The altered blood aldosterone was retrospectively analyzed after infusion of saline. Moreover, ROC curve was used for the suitable tangent point in order to diagnose PA. Results The area under the curve ( AUC ) of blood aldosterone was 0. 975 after saline infusion (0. 959 -0. 986). Difference was found between AUC and the area under the referential curve (0. 5) (P 〈0. 01 ). After infusion of saline, the sensitivity and specificity of PA diagnosis were 93% and 97. 8% under circumstance of blood aldosteronc 〉 100 ng/L,respectively. Conclusion The saline infusion inhibition test might be used as the confirmatory test for diagnosis of PA.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2012年第7期529-532,共4页 Chinese Journal of Practical Internal Medicine
基金 上海市科委生物医药重点项目(09411954400) 上海市科委学科带头人计划(10XD1403000)
关键词 原发性醛固酮增多症 醛固酮/肾素比值 生理盐水试验 primary aldosteronism aldosterone/renin ratio saline infusion test
  • 相关文献

参考文献9

  • 1Mulatero P. Increased Diagnosis of Primary Aldosteronism, Including Surgically Correctable Forms,in Centers from Five Continents [ J]. Journal of Clinical Endocrinology & Metabolism, 2004, 89 ( 3 ) : 1045 - 1050.
  • 2Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosterenism in 1,125 hypertensive patients [ J ]. J Am Coll C ardiol,2006,48 (11 ) :2293 -2300.
  • 3Umpierrez GE, Cantey P, Smiley D, et al. Primary aldosteronism in diabetic subjects with resistant hypertension [ J ]. Diabetes Care, 2007,30(7) :1699 - 1703.
  • 4Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism [ J]. J Am Coll Cardiol,2005,45 (8) : 1243 - 1248.
  • 5Rossi GP,Bernini G,Desideri G,et at. Renal damage in primary al- dosteronism : results of the PAPY Study [ J ]. Hypertension,2006,48 (2) :232 -238.
  • 6Funder JW, Carey RM, Fardella C, et at. Case detection, diagnosis, and treatment of patients with primary atdosteronism: an endocrine society clinical practice guideline [ J ]. J Clin Endocrinol Metab, 2008,93 (9) :3266 - 3281.
  • 7Mulatero P, Milan A, Fallo F, et al. Comparison of confirmatory tests for the diagnosis of primary aldosteronism [ J ]. J Clin Endocrianl Metal) ,2006,91 (7) :2618 - 2623.
  • 8Mysliwiec J, Zukowski L, Grodzka A, et al. Diagnostics of primary al- dostemnism:is obligatory use of confirmatory tests justified? [J]. J Renin Angiotensin Aldosterone Syst,2012.
  • 9Rossi GP, Belfiore A, Bernini G, et al. Prospectiye evaluation of the saline infusion test for excluding primary aldosteronism due to aldo- sterone-producing adenoma[J].J Hypertens ,2007,25 (7) : 1433 - 1442.

同被引文献27

  • 1陈绍行,杜月凌,张瑾,龚艳春,胡亚蓉,初少莉,何清波,宋艳艳,朱鼎良.在高血压患者中筛选原发性醛固酮增多症国人血浆醛固酮/肾素活性比值标准的探讨[J].中华心血管病杂志,2006,34(10):868-872. 被引量:48
  • 2张炜,汤正义,吴景程,王卫庆,宁光.静脉盐水负荷试验在原发性醛固酮增多症诊断中的应用[J].上海交通大学学报(医学版),2007,27(6):703-705. 被引量:22
  • 3陆召麟,宁光.内分泌内科学.第1版.北京:人民卫生出版社,2009:108.
  • 4Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism : an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2008,93:3266-3281.
  • 5Tiu SC, Choi CH, Shek CC, et al. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab, 2005,90:72-78.
  • 6Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coil Cardiol, 2006,48:2293-2300.
  • 7Hirohara D, Nomura K, Okamoto T, et al. Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone- producing adenoma in low renin hypertensives. J Cfin Endocrinol Metab, 2001, 86:4292-4298.
  • 8Giacchetti G, Ronconi V, Lucarelli G, ct al. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens, 2006, 24:737-745.
  • 9Gosse P, Guihenenf-Tobie C, Lasserre R, et al. Biochemical detection of Conn's adenoma: definition of criteria and reference values. Arch Mal Coeur Vaiss, 2005, 98:181-185.
  • 10Rossi GP, Belilore A, Bemini G, et al. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. J Hypertens, 2007,25 : 1433-1442.

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部